Literature DB >> 19026257

A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects.

Sara B Fleet-Michaliszyn1, Isabella Soreca, Amy D Otto, John M Jakicic, Andrea Fagiolini, David J Kupfer, Bret H Goodpaster.   

Abstract

OBJECTIVE: Patients with bipolar disorder are at increased risk for diabetes and cardiovascular diseases, possibly because of more severe insulin resistance. The primary purpose of this study was to determine whether insulin resistance is characteristic of bipolar disorder.
METHOD: The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was performed in 18 women with DSM-IV bipolar I disorder, and results were compared to those of 17 matched controls. Other risk factors were compared, including blood pressure, blood lipids, and abdominal obesity by computed tomography (CT). Additionally, substrate utilization was measured by indirect calorimetry, and free-living energy expenditure was estimated using wearable activity monitors. All data were collected between February 2006 and December 2007.
RESULTS: Patients with bipolar disorder were no more insulin resistant than controls after accounting for generalized obesity (mean +/- SEM HOMA-IR = 2.7 +/- 0.7 vs. 2.5 +/- 0.7, for patients and controls, respectively; p = .79). Although blood lipid profiles were generally similar in patients and controls, obese patients had higher blood pressure than controls. Obese patients had more mean +/- SEM total abdominal fat (718.1 +/- 35.1 cm² vs. 607.4 +/- 33.6 cm²; p = .04), and tended (p = .06) to have more visceral abdominal fat. Patients oxidized 13% less fat during resting conditions, although their resting metabolic rate was similar to that of controls.
CONCLUSION: Women with bipolar I disorder were no more insulin resistant than matched controls after accounting for their level of obesity. However, they were more hypertensive, had higher amounts of abdominal obesity, and had reduced rates of fat oxidation. Therefore, women with bipolar I disorder may be at a heightened risk for future weight gain and concomitant risk for diabetes and cardiovascular disease. Copyright 2008 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19026257      PMCID: PMC3428955          DOI: 10.4088/jcp.v69n1207

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  48 in total

1.  Measurement reliability and reactivity using repeated measurements of resting energy expenditure with a face mask, mouthpiece, and ventilated canopy.

Authors:  T R Isbell; R C Klesges; A W Meyers; L M Klesges
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 Mar-Apr       Impact factor: 4.016

Review 2.  The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms.

Authors:  Roger S McIntyre; Joanna K Soczynska; Jakub Z Konarski; Sidney H Kennedy
Journal:  Expert Opin Drug Saf       Date:  2006-01       Impact factor: 4.250

3.  Evaluation of a portable device to measure daily energy expenditure in free-living adults.

Authors:  Maxime St-Onge; Diane Mignault; David B Allison; Rémi Rabasa-Lhoret
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

4.  Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.

Authors:  A Erenmemisoglu; U K Ozdogan; R Saraymen; A Tutus
Journal:  J Pharm Pharmacol       Date:  1999-06       Impact factor: 3.765

5.  Overweight and obesity in the United States: prevalence and trends, 1960-1994.

Authors:  K M Flegal; M D Carroll; R J Kuczmarski; C L Johnson
Journal:  Int J Obes Relat Metab Disord       Date:  1998-01

6.  Novel antipsychotics: comparison of weight gain liabilities.

Authors:  D A Wirshing; W C Wirshing; L Kysar; M A Berisford; D Goldstein; J Pashdag; J Mintz; S R Marder
Journal:  J Clin Psychiatry       Date:  1999-06       Impact factor: 4.384

7.  Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

Authors:  P Lempiäinen; L Mykkänen; K Pyörälä; M Laakso; J Kuusisto
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

8.  Prevalence of pre-obesity and obesity in urban adult Mexicans in comparison with other large surveys.

Authors:  P Arroyo; A Loria; V Fernández; K M Flegal; P Kuri-Morales; G Olaiz; R Tapia-Conyer
Journal:  Obes Res       Date:  2000-03

9.  Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.

Authors:  F Cassidy; E Ahearn; B J Carroll
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

10.  Obesity and metabolic syndrome in a psychiatric rehabilitation service.

Authors:  Srinivasan Tirupati; Ling-Ern Chua
Journal:  Aust N Z J Psychiatry       Date:  2007-07       Impact factor: 5.744

View more
  10 in total

1.  PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.

Authors:  David E Kemp; Martha Schinagle; Keming Gao; Carla Conroy; Stephen J Ganocy; Faramarz Ismail-Beigi; Joseph R Calabrese
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

2.  The burden of obesity among adults with bipolar disorder in the United States.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Nevena Zivkovic; Ayal Schaffer; Lung-Chang Chien; Carlos Blanco
Journal:  Bipolar Disord       Date:  2011-06       Impact factor: 6.744

3.  Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.

Authors:  Natalie L Rasgon; Heather A Kenna; Margaret F Reynolds-May; Pascale G Stemmle; Mytilee Vemuri; Wendy Marsh; Po Wang; Terence A Ketter
Journal:  Bipolar Disord       Date:  2010-08       Impact factor: 6.744

4.  Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome.

Authors:  David E Kemp; Keming Gao; Philip K Chan; Stephen J Ganocy; Robert L Findling; Joseph R Calabrese
Journal:  Bipolar Disord       Date:  2010-06       Impact factor: 6.744

Review 5.  Mania and mortality: why the excess cardiovascular risk in bipolar disorder?

Authors:  Dylan P Murray; Miriam Weiner; Maithri Prabhakar; Jess G Fiedorowicz
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 6.  Obesity in bipolar disorder: an overview.

Authors:  Susan L McElroy; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

7.  Obesity and the three-year longitudinal course of bipolar disorder.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Ayal Schaffer; Regina Sala; Carlos Blanco
Journal:  Bipolar Disord       Date:  2013-01-03       Impact factor: 6.744

Review 8.  Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications.

Authors:  Ellen F Charles; Christophe G Lambert; Berit Kerner
Journal:  Int J Bipolar Disord       Date:  2016-07-07

9.  Differential effects on neurodevelopment of FTO variants in obesity and bipolar disorder suggested by in silico prediction of functional impact: An analysis in Mexican population.

Authors:  Erasmo Saucedo-Uribe; Alma Delia Genis-Mendoza; Adriana Díaz-Anzaldúa; José Jaime Martínez-Magaña; Carlos Alfonso Tovilla-Zarate; Isela Juárez-Rojop; Nuria Lanzagorta; Michael Escamilla; Thelma Beatriz González-Castro; María Lilia López Narvaez; Yazmín Hernández-Díaz; Humberto Nicolini
Journal:  Brain Behav       Date:  2019-04-29       Impact factor: 2.708

Review 10.  Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review.

Authors:  Young Sup Woo; Hye-Jin Seo; Roger S McIntyre; Won-Myong Bahk
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.